Skip to content
Monday, June 27, 2022
Latest:
  • A potentially more effective treatment for HER2 mutant metastatic breast cancer
  • Finding pain relief in the kitchen
  • The 10th Annual Research Symposium of the Michael E. DeBakey Department of Surgery
  • All about autoimmune diseases
  • Welcome new School of Health Professions students!

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

Immunotherapy

From The Labs 

Study of spliceosome-targeting cancer therapies reveals an overlooked role of mis-spliced RNAs themselves

January 19, 2021January 19, 2021apoptosis, cancer treatment, Immunotherapy, Research, RNA splicing, Spliceosome-targeting therapies, triple-negative breast cancer

Endogenous mis-spliced RNA in tumor cells mimics an RNA virus, leading tumor cells to self-destruct as if fighting an infection.

Read more
From The Labs 

CAR NKT cells, a promising step forward in the treatment of solid tumors

November 10, 2020November 10, 2020CAR NK T cells, clinical trial, Immunotherapy, neuroblastoma, Research, solid tumors

An ongoing clinical trial shows that human CAR NKT cells are safe and, in 1 of 3 patients, induced regression of metastatic lesions.

Read more
From The Labs 

New insights into the mediators of patient recovery after CAR T cell immunotherapy

July 21, 2020July 28, 2020cancer therapy, CAR T cell, Clinical Trials, complete response, HER-2, Immunotherapy, Research, rhabdomyosarcoma

Clinical trial of novel personalized CAR T cell immunotherapy provides clues into what mediated exceptional patient recovery.

Read more
Samir-Tanios-CRI
Momentum 

Immunotherapy improves quality of life for mesothelioma patient

November 19, 2019November 18, 2019Cancer, Dan L Duncan Comprehensive Cancer Center, Healthcare, Immunotherapy, Mesothelioma, Molly Chiu

When Samir Tanios was diagnosed with malignant pleural mesothelioma in September 2018, he was in poor condition. He couldn’t take a deep breath  or walk

Read more
Momentum 

Body of Work podcast: Harnessing the body’s immune system to fight cancer

September 16, 2019September 16, 2019Body of Work, Cancer, Immunotherapy

By 2030, the number of new cancer cases per year is expected to increase by 23.6 million worldwide. While radiation and chemotherapy continue to be

Read more
From The Labs 

Immunotherapy for pancreatic cancer shows promise

July 23, 2019July 24, 2019Conference, Immunotherapy, pancreatic cancer, Research, T cell therapy

Pancreatic cancer is one of the most challenging types of cancer to treat, but new therapy using the body’s own immune system is providing new

Read more
melanoma-nci-photo-featured
Momentum 

How immunotherapy is improving outlook for melanoma patients

June 4, 2019June 4, 2019Cancer, Dan L Duncan Comprehensive Cancer Center, Healthcare, Immunotherapy, melanoma, Nicole Blanton, Skin Cancer

Melanoma is the deadliest form of skin cancer in the world. While traditional therapies include chemotherapy, radiation, and surgery, immunotherapy has emerged as an effective

Read more
From The Labs 

From the labs to bedside: First-in-human trial shows promise in treating neuroblastoma

May 28, 2019May 28, 2019chimeric antigen, Clinical Trials, GD2, GD2-CAR, Immunotherapy, neuroblastoma, Research

Neuroblastoma is the most common extracranial solid cancer in children, and patients with high-risk disease are challenging to treat. In April, during the annual meeting of

Read more
From The Labs 

Special delivery of IL-7 signaling makes all the difference for CAR T cells fighting solid tumors

May 15, 2018May 15, 2018brain tumor, CAR T cells, IL7, Immunotherapy, Research, solid tumors

Since he was in college, Thomas Shum wanted to pursue a career in cancer research. As he advanced in his studies, he was able to

Read more
dill-team-featured
Momentum 

Immunotherapy treatment gives lung cancer patient second chance

January 22, 2018January 22, 2018Cancer, Dan L Duncan Comprehensive Cancer Center, Immunotherapy, Nicole Blanton

A few years ago, Katherine Dill was leading a full life with her two children in Texas when she noticed something different about her face.

Read more
  • ← Previous

From the Labs Image of the Month

From The Labs Image of the Month From the Labs: A selection of From the Labs Images of the Month on display in the A Hallway at Main Baylor.

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951